BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 28389776)

  • 1. Senotherapy: growing old and staying young?
    Schmitt R
    Pflugers Arch; 2017 Sep; 469(9):1051-1059. PubMed ID: 28389776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting normal and cancer senescent cells as a strategy of senotherapy.
    Sikora E; Bielak-Zmijewska A; Mosieniak G
    Ageing Res Rev; 2019 Nov; 55():100941. PubMed ID: 31408714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Senotherapy, cancer, and aging.
    Balducci L; Falandry C; Silvio Monfardini
    J Geriatr Oncol; 2024 May; 15(4):101671. PubMed ID: 37977898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of resibufogenin, a component of toad venom, as a novel senolytic compound in vitro and for potential skin rejuvenation in male mice.
    Takaya K; Asou T; Kishi K
    Biogerontology; 2023 Dec; 24(6):889-900. PubMed ID: 37395866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular senescence in the aging and diseased kidney.
    Valentijn FA; Falke LL; Nguyen TQ; Goldschmeding R
    J Cell Commun Signal; 2018 Mar; 12(1):69-82. PubMed ID: 29260442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interacting NAD
    Mendelsohn AR; Larrick JW
    Rejuvenation Res; 2019 Jun; 22(3):261-266. PubMed ID: 31140365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular senescence in cardiac diseases.
    Shimizu I; Minamino T
    J Cardiol; 2019 Oct; 74(4):313-319. PubMed ID: 31202488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs against metabolic diseases as potential senotherapeutics for aging-related respiratory diseases.
    Matsubayashi S; Ito S; Araya J; Kuwano K
    Front Endocrinol (Lausanne); 2023; 14():1079626. PubMed ID: 37077349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Senescent cells in cancer therapy: why and how to remove them.
    Zhang JW; Zhang D; Yu BP
    Cancer Lett; 2021 Nov; 520():68-79. PubMed ID: 34237406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice.
    Roos CM; Zhang B; Palmer AK; Ogrodnik MB; Pirtskhalava T; Thalji NM; Hagler M; Jurk D; Smith LA; Casaclang-Verzosa G; Zhu Y; Schafer MJ; Tchkonia T; Kirkland JL; Miller JD
    Aging Cell; 2016 Oct; 15(5):973-7. PubMed ID: 26864908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deconstructing cellular senescence in bone and beyond.
    Hofbauer LC; Lademann F; Rauner M
    J Clin Invest; 2023 Apr; 133(8):. PubMed ID: 37066877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular Senescence: A Translational Perspective.
    Kirkland JL; Tchkonia T
    EBioMedicine; 2017 Jul; 21():21-28. PubMed ID: 28416161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Senescence and senolytics in cardiovascular disease: Promise and potential pitfalls.
    Owens WA; Walaszczyk A; Spyridopoulos I; Dookun E; Richardson GD
    Mech Ageing Dev; 2021 Sep; 198():111540. PubMed ID: 34237321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Emerging Role of Senotherapy in Cancer: A Comprehensive Review.
    Malayaperumal S; Marotta F; Kumar MM; Somasundaram I; Ayala A; Pinto MM; Banerjee A; Pathak S
    Clin Pract; 2023 Jul; 13(4):838-852. PubMed ID: 37489425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers to identify and isolate senescent cells.
    Matjusaitis M; Chin G; Sarnoski EA; Stolzing A
    Ageing Res Rev; 2016 Aug; 29():1-12. PubMed ID: 27212009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Senotherapeutics in Cancer and HIV.
    Sánchez-Díaz L; Espinosa-Sánchez A; Blanco JR; Carnero A
    Cells; 2022 Apr; 11(7):. PubMed ID: 35406785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From Development to Aging: The Path to Cellular Senescence.
    Sacco A; Belloni L; Latella L
    Antioxid Redox Signal; 2021 Feb; 34(4):294-307. PubMed ID: 32228062
    [No Abstract]   [Full Text] [Related]  

  • 18. Targeting senescent cells for vascular aging and related diseases.
    Ding YN; Wang HY; Chen HZ; Liu DP
    J Mol Cell Cardiol; 2022 Jan; 162():43-52. PubMed ID: 34437878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Emergence of Senescent Surface Biomarkers as Senotherapeutic Targets.
    Rossi M; Abdelmohsen K
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Senolysis Approach via Antibody-Drug Conjugate Targeting of the Senescent Cell Marker Apolipoprotein D for Skin Rejuvenation.
    Takaya K; Asou T; Kishi K
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.